SICKLE CELL DISEASE THERAPY- ADDENDUM 

NIH GUIDE, Volume 25, Number 1, January 26, 1996

 

RFA:  HL-96-001

 

P.T. 34



Keywords:

  Blood Diseases 

  Biology, Cellular 

  Biology, Molecular 

  Chemotherapeutic Agents 

 

National Heart, Lung, and Blood Institute

 

Letter of Intent Receipt Date:  February 20, 1996 (Revised)

Application Receipt Date:  March 19, 1996 (Revised)

 

The National Heart, Lung, and Blood Institute of the National

Institutes of Health (NIH) announces the following modification to

RFA HL-96-001, which was published in the NIH Guide, Vol. 24, No. 40,

November 24, 1995.

 

Schedule

 

The letter of intent receipt date is extended from December 22, 1995

to February 20, 1996.  The application receipt date is extended from

January 23, 1996 to March 19, 1996.  The anticipated award date is

September 1996.

 

Direct inquiries regarding programmatic issues to:

 

Dr. Junius G. Adams, III

Division of Blood Diseases and Resources

National Heart, Lung, and Blood Institute

6701 Rockledge Drive

Bethesda, MD  20892-7950

Telephone:  (301) 435-0055

FAX:  (301) 480-0868

Email:  ja33m@nih.gov

 

Inquiries regarding fiscal matters or collaborative arrangements

involving subcontracts with other institutions may be directed to:

 

Ms. Jane R. Davis

Blood Division Grants Management Section

National Heart, Lung, and Blood Institute

6701 Rockledge Drive

Bethesda, MD  20892-7926

Telephone:  (301) 435-0166

FAX:  (301) 480-3310

 

.


Return to 1996 Index

Return to NIH Guide Main Index


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.